ESBL-producing Escherichia coli and Klebsiella pneumoniae : The most prevalent clinical isolates obtained between 2005 and 2012 in Mexico
- 1 September 2017
- journal article
- research article
- Published by Elsevier in Journal of Global Antimicrobial Resistance
- Vol. 10, 243-246
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Characterization of Enterobacteriaceae Isolates Obtained from a Tertiary Care Hospital in Mexico, Which Produces Extended-Spectrum β-LactamaseMicrobial Drug Resistance, 2013
- Extended-spectrum β-Lactamase-Producing Enterobacteriaceae Causing Nosocomial Infections in Mexico. A Retrospective and Multicenter StudyArchives of Medical Research, 2011
- Molecular characterization and antimicrobial susceptibility of extended-spectrum β-lactamase-producing Enterobacteriaceae isolates at a tertiary-care centre in Monterrey, MexicoJournal of Medical Microbiology, 2011
- Association of the Extended-Spectrum β-Lactamase Gene bla TLA-1 with a Novel IS CR Element, IS CR20Antimicrobial Agents and Chemotherapy, 2010
- Identification of SHV-Type and CTX-M-12 Extended-Spectrum β-Lactamases (ESBLs) in MultiresistantEnterobacteriaceaefrom Colombian Caribbean HospitalsJournal of Chemotherapy, 2010
- Molecular epidemiology and risk factors of bloodstream infections caused by extended-spectrum β-lactamase-producing Klebsiella pneumoniaeInternational Journal of Infectious Diseases, 2008
- The CTX-M β-lactamase pandemicCurrent Opinion in Microbiology, 2006
- Nosocomial Spread of Ceftazidime-Resistant Klebsiella pneumoniae Strains Producing a Novel Class A β-Lactamase, GES-3, in a Neonatal Intensive Care Unit in JapanAntimicrobial Agents and Chemotherapy, 2004
- Extended-Spectrum β-Lactamases in the 21st Century: Characterization, Epidemiology, and Detection of This Important Resistance ThreatClinical Microbiology Reviews, 2001
- Rapid and Simple Determination of the Escherichia coli Phylogenetic GroupApplied and Environmental Microbiology, 2000